240
Participants
Start Date
June 30, 2006
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
Ropinirole
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Bad Saarow
GSK Investigational Site, Anklam
GSK Investigational Site, Schwerin
GSK Investigational Site, Wismar
GSK Investigational Site, Oldenburg in Holstein
GSK Investigational Site, Achim
GSK Investigational Site, Hildesheim
GSK Investigational Site, Gütersloh
GSK Investigational Site, Bielefeld
GSK Investigational Site, Kassel
GSK Investigational Site, Butzbach
GSK Investigational Site, Herborn
GSK Investigational Site, Göttingen
GSK Investigational Site, Göttingen
GSK Investigational Site, Wolfsburg
GSK Investigational Site, Düsseldorf
GSK Investigational Site, Bochum
GSK Investigational Site, Bochum
GSK Investigational Site, Bochum
GSK Investigational Site, Bochum
GSK Investigational Site, Bochum
GSK Investigational Site, Hattingen
GSK Investigational Site, Gelsenkirchen
GSK Investigational Site, Düren
GSK Investigational Site, Jülich
GSK Investigational Site, Bad Homburg
GSK Investigational Site, Limburgerhof
GSK Investigational Site, Ellwangen
GSK Investigational Site, Ostfildern
GSK Investigational Site, Freiburg im Breisgau
GSK Investigational Site, Munich
GSK Investigational Site, Unterhaching
GSK Investigational Site, Ulm
GSK Investigational Site, Ulm
GSK Investigational Site, Nuremberg
GSK Investigational Site, Regensburg
GSK Investigational Site, Würzburg
GSK Investigational Site, Dresden
GSK Investigational Site, Halle
GSK Investigational Site, Köthen
GSK Investigational Site, Gera
GSK Investigational Site, Jena
Lead Sponsor
GlaxoSmithKline
INDUSTRY